To determine whether SUMOylation of SIRT3 also participates in AML chemoresistance, SIRT3 SUMOylation was detected in AML cells upon treatment either with 2.5 μM Ara-C or 50 nM DNR at 48 h time points. The gene discussed is SIRT3; the disease is acute myeloid leukemia.